EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Identi Healthcare Ltd (IDNT) fair value: what the stock is really worth

As of Oct 8, 2026: fair value of Identi Healthcare Ltd ILS 0.33, price ILS 1.61, upside -79.5%, quality 46 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · Il · ISIN IL0011774507

IH Thin data Oct 3, 2026

Identi Healthcare Ltd

IDNT · TA

Weakest SetupStrongly overvalued and low quality.

Quality 46/100
Expensive Growth (revenue 5y +6.9 %/yr in ILA)
Fair value 0.3300 ILA · Strongly overvalued (−79.5%)
Loss-making · -38.1% net margin (TTM)
Negative free cash flow
Trails peers (3/9)
Narrow moat 12/100
Thin data
Watch Identi Healthcare Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

8.90 ILA 1.22 ILA Fair Value 0.3300 ILA Jun 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.

How to read this chart

60‑month range 1.22 ILA – 8.90 ILA · fair‑value band 0.2200 ILA – 0.4100 ILA · the 1.61 ILA price screens above the 0.3300 ILA fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.

Follow Identi Healthcare in your weekly email

Every Wednesday you see whether Identi Healthcare is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Identi Healthcare Ltd provides healthcare inventory management systems.

Show more

Identi Healthcare Ltd provides healthcare inventory management systems. It offers Snap & Go, an image recognition technology to record medical implants and consumables used during surgery; RFID Smart Cabinet, an automated inventory system developed to helps cath labs, neurosurgery, ophthalmology, EP labs, orthopedics, plastic surgery, gastro, and other; and Narcotics Cabinet, an automated system for the administration of controlled substances and narcotics. The company also provides Kanban & PAR solutions, including Smart Weighing Bin, a wireless and autonomous smart scale bin that re-orders its own supplies; Restock Tag, a solution that automatically replenishes inventory by clicking a button; and Scan & Restock, a mobile App to order and monitor orders. In addition, it offers IDENTIPlatform, a cloud-based platform powered by artificial intelligence and machine learning that connects suppliers to hospitals; and gas cylinder stock management and curtain disinfection and cleaning services. The company was incorporated in 2017 and is headquartered in Netanya, Israel.

Stock analysis

Identi Healthcare Ltd (IDNT) currently trades at 1.61 ILA, while our model-based Fair Value estimate is 0.3300 ILA, 79.5% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 81/100, which puts the evidence level at low.

Scenario range: 0.2200 ILA (bear) to 0.4100 ILA (bull), the price of 1.61 ILA sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Identi Healthcare Ltd reported revenue of 9.9M ILA in FY2025 versus 8.1M ILA in FY2021, a compound +5.2%/yr. Reported net income was −5.8M ILA in FY2025.

Key figures

Market cap 26.0M ILA · P/S ratio 2.09 · EPS (TTM) −18.78 ILA · Net margin −58.3% · Return on equity −72.8% · Return on assets (EBIT) −42.0% · Operating margin −25.0% · Revenue (TTM) 12.4M ILA.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).

What moves the price

The share trades about 28% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −79%, IDNT screens richer than that median.

Fair Value models

Bear 0.2200 ILA Fair Value 0.3300 ILA Bull 0.4100 ILA
Price 1.61 ILA · Upside -79.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) 0.2100 ILA 0.2900 ILA 0.4300 ILA 51
All 1 models by family
Asset-Based
NCAV (Graham) 0.2100 ILA 0.2900 ILA 0.4300 ILA 51

Open the full fair value analysis →

Quality Score breakdown

Overall quality 46/100

Of which business quality 46 · Market factors (momentum, volatility) 33

Profitability 26
Margins and returns on capital today
Quality Growth 58
Are margins and returns improving?
Cashflow 9
Earnings quality: real cash, not paper profit
Fin. Strength 71
Balance sheet, leverage, solvency risk
Investment 91
Disciplined investing over empire-building
Low Volatility 66
Calm price path (market factor)
Momentum 27
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 43
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 21/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−1.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.9%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−0.7% (2020) → −56.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

IDNT screens overvalued: fair value 79% below the price. Compare with Veeva Systems Inc →

Compare Identi Healthcare Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 117 stocks

Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 46 · Below median
Fair Value upside −79.5% · Bottom 25%
Profitability
Return on assets −18.3% · Bottom 25%
Net margin (TTM) −38.1% · Bottom 25%
Operating margin (TTM) −25.0% · Bottom 25%
Growth and dividend
Revenue growth 51.4% · Top 25%

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 1.35× · Cheaper than median
P/S (TTM) 0.68× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)100 · sector 41
PAST (return on equity)0 · sector 11
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)0 · sector 43

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Veeva Systems Inc VEEV $273.33 $300.66 +10% vs IDNT
HealthEquity, Inc HQY $88.44 $97.28 +10% vs IDNT
Waystar Holding WAY $24.70 $27.17 +10% vs IDNT
Doximity, Inc DOCS $30.50 $33.55 +10% vs IDNT
Inventurus Knowledge Solutions Limited IKS ₹1,779 ₹1,883 +6% vs IDNT
Hinge Health, Inc HNGE $95.57 $51.25 −46% vs IDNT
Pro Medicus Limited PME A$161.00 A$84.62 −47% vs IDNT
BrightSpring Health Services, Inc BTSG $56.54 $25.86 −54% vs IDNT
Privia Health Group PRVA $19.62 $5.02 −74% vs IDNT
XtalPi Holdings 2228 HK$7.75 HK$1.50 −81% vs IDNT

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Identi Healthcare Ltd · Fair Value
0.3300 ILA −79%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Identi Healthcare Ltd Fair Value". https://www.fairvalue-calculator.com/stock/IDNT

Frequently asked questions

Is Identi Healthcare Ltd (IDNT) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of 0.3300 ILA versus a price of 1.61 ILA, about −79% upside (overvalued).
What is the fair value of IDNT?
Our model-based fair value for Identi Healthcare Ltd is 0.3300 ILA (as of Oct 3, 2026), built from audited fundamentals. The current price: 1.61 ILA.
What is the quality score of IDNT?
Identi Healthcare Ltd has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Identi Healthcare Ltd (IDNT)?
Our model-based price target is the fair value of 0.3300 ILA (as of Oct 3, 2026) from 1 valuation models. Cautious scenario 0.2200 ILA, optimistic scenario 0.4100 ILA. It is a calculation from audited fundamentals, not an analyst target.
What is the Identi Healthcare Ltd stock forecast for 2026?
Our models put fair value at 0.3300 ILA, about −79% upside versus a price of 1.61 ILA (overvalued). Cautious scenario 0.2200 ILA, optimistic scenario 0.4100 ILA. The calculation is refreshed regularly with new filings.
What is the revenue of Identi Healthcare Ltd (IDNT)?
Identi Healthcare Ltd reported trailing-twelve-month revenue of about 12.4M ILS (latest available figure, as of Oct 3, 2026).
What is the intrinsic value of Identi Healthcare Ltd (IDNT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Identi Healthcare Ltd it is 0.3300 ILA per share (as of Oct 3, 2026), against a price of 1.61 ILA. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Identi Healthcare Ltd stock overvalued or undervalued in 2026?
As of Oct 3, 2026, IDNT trades above its calculated fair value: price 1.61 ILA, fair value 0.3300 ILA, a gap of about −79% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of IDNT?
No. The price is what the market pays today (1.61 ILA); the fair value is what the company's own numbers justify (0.3300 ILA). For Identi Healthcare Ltd the two are 1.28 ILA per share apart. That gap is exactly why we show both numbers side by side.
How much is Identi Healthcare Ltd worth?
The market values Identi Healthcare Ltd at about 26.0M ILA (market capitalisation, as of Oct 3, 2026). Per share that is 1.61 ILA; our models calculate a fair value of 0.3300 ILA per share.
What do the bullish and bearish scenarios say about IDNT?
Our models span a range for Identi Healthcare Ltd: cautious scenario 0.2200 ILA, base 0.3300 ILA, optimistic 0.4100 ILA per share (as of Oct 3, 2026, price 1.61 ILA). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Identi Healthcare Ltd (IDNT)?
Balance-sheet figures for Identi Healthcare Ltd (as of Oct 3, 2026): return on equity −72.8%. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is IDNT from its 52-week high?
Identi Healthcare Ltd trades at 1.61 ILA, about 28% below its 52-week high of 2.23 ILA and 2% above the low of 1.57 ILA (as of Oct 8, 2026). Distance from the high says nothing about value: that is what the fair value of 0.3300 ILA is for.
Which stocks are comparable to Identi Healthcare Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Identi Healthcare Ltd stock attractive at the current price?
The data as of Oct 3, 2026: price 1.61 ILA, calculated fair value 0.3300 ILA (−79%), Quality Score 46/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of IDNT calculated?
We run Identi Healthcare Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.3300 ILA, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Identi Healthcare Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Identi Healthcare Ltd (IDNT)?
The closing price on Oct 8, 2026 was 1.61 ILA. Our model-based fair value is 0.3300 ILA, about −79% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Identi Healthcare Ltd right now?
The price sits above even our optimistic bull case (0.4100 ILA). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (0.2200 ILA to 0.4100 ILA) leaves room in how you read the outcome.

Key figures of Identi Healthcare Ltd

How large is the market capitalisation of Identi Healthcare Ltd (IDNT)?
The market capitalisation of Identi Healthcare Ltd is 26.0M ILA. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Identi Healthcare Ltd (IDNT)?
The price-to-sales ratio of Identi Healthcare Ltd is 2.09 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Identi Healthcare Ltd (IDNT)?
Earnings per share at Identi Healthcare Ltd are −18.78 ILA. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Identi Healthcare Ltd (IDNT)?
The net margin of Identi Healthcare Ltd is −58.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Identi Healthcare Ltd (IDNT)?
The return on equity (ROE) of Identi Healthcare Ltd is −72.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Identi Healthcare Ltd (IDNT)?
On an EBIT basis the return on assets of Identi Healthcare Ltd is −42.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Identi Healthcare Ltd (IDNT)?
The operating margin of Identi Healthcare Ltd is −25.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Identi Healthcare Ltd (IDNT)?
Revenue at Identi Healthcare Ltd is growing +51.4% versus a year earlier (3y avg +1.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Identi Healthcare Ltd (IDNT) generate?
The free cash flow of Identi Healthcare Ltd is −5.9M ILA (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Identi Healthcare Ltd (IDNT) hold?
Identi Healthcare Ltd holds more cash than debt, 2.9M ILA net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Identi Healthcare Ltd in the live analysis

One click puts Identi Healthcare Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.